Sam L. Barker, Director at LEXICON PHARMACEUTICALS, INC. (LXRX), bought 1,000 shares at $12.50 ($13K) on 2017-09-15, disclosed to the SEC on 2017-09-18.
Open-market purchase of $12k LXRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| LXRX | BUY | 2019-08-02 | $28K | — | Filing → |
| CYCC | BUY | 2014-11-20 | $9K | — | Filing → |
| CADX | BUY | 2011-05-11 | $63K | — | Filing → |